Arava and Ruxience drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arava (leflunomide) and Ruxience (rituximab-pvvr). Common drug interactions include fracture among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Arava and Ruxience. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Arava?

Arava has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 76,040 Arava users. Check the latest studies of Arava.

What is Ruxience?

Ruxience has active ingredients of rituximab-pvvr. eHealthMe is studying from 4,260 Ruxience users. Check the latest studies of Ruxience.



On Jul, 19, 2026

76 people who take Arava and Ruxience together, and have interactions are studied.

Arava and Ruxience drug interactions.

What are the common drug interactions of Arava and Ruxience, by gender? *:

female:

  1. Fracture
  2. Hip fracture
  3. Multiple fractures
  4. Anaemia (lack of blood)
  5. Rash
  6. Gait disturbance
  7. Pericarditis (inflammation of the pericardium)
  8. Vasculitis (inflammation of a blood vessel or blood vessels)
  9. Arthralgia (joint pain)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

  1. Fatigue (feeling of tiredness)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Disease recurrence
  4. Dyspnoea (difficult or laboured respiration)
  5. Interstitial lung disease
  6. Joint swelling
  7. Rheumatoid nodule (a local swelling or tissue lump with rheumatoid disease)
  8. Localised infection (infection at the single location)
  9. Idiopathic pulmonary fibrosis (chronic lung disease)
  10. Balance disorder

What are the common drug interactions of Arava and Ruxience, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Fatigue (feeling of tiredness)
  2. Throat tightness
  3. Anxiety
  4. Back pain
  5. Cough
  6. Dyspnoea (difficult or laboured respiration)
  7. Gait disturbance
  8. Headache (pain in head)
  9. Influenza
  10. Joint stiffness

40-49:

  1. Headache (pain in head)
  2. Eye pruritus (eye itching)
  3. Cough
  4. Dyspnoea (difficult or laboured respiration)
  5. Arthralgia (joint pain)
  6. Cardiovascular insufficiency (inadequate functioning of heart)
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Disease recurrence
  9. Fatigue (feeling of tiredness)
  10. Influenza

50-59:

  1. Red blood cell sedimentation rate increased
  2. Anal fissure
  3. Blood pressure diastolic increased
  4. Blood pressure increased
  5. Blood pressure systolic increased
  6. C-reactive protein increased
  7. Infusion related reaction
  8. Kidney infection
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Nasopharyngitis (inflammation of the nasopharynx)

60+:

  1. Cataract (clouding of the lens inside the eye)
  2. Impaired driving ability
  3. Hip fracture
  4. Multiple fractures
  5. Anaemia (lack of blood)
  6. Idiopathic pulmonary fibrosis (chronic lung disease)
  7. Erythema (redness of the skin)
  8. Drug ineffective
  9. Cardiac failure congestive
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Pneumonia: 4 people, 5.26%
  2. Indigestion: 4 people, 5.26%
  3. Diarrhea: 4 people, 5.26%
  4. Corneal Deposits: 4 people, 5.26%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Arava and Ruxience?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arava and Ruxience:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ruxience:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arava and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ruxience and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on leflunomide and rituximab-pvvr (the active ingredients of Arava and Ruxience, respectively), and Arava and Ruxience (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: